Efficacy and safety of omalizumab in the treatment of the chronic urticaria

被引：0
|
作者：
Fages Perez, M. [1 ]
Soria Martin, A. [1 ]
Romero Puerto, J. [1 ]
Villanueva Jimenez, P. [1 ]
Avila Alvarez, J. R. [1 ]
机构：
[1] Hosp Punta Europa, Cadiz, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT021
引用
下载
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [31] Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19
    Passante, Maria
    Napolitano, Maddalena
    Dastoli, Stefano
    Bennardo, Luigi
    Fabbrocini, Gabriella
    Nistico, Steven Paul
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2021,
  • [32] Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
    Maurer, Marcus
    Altrichter, Sabine
    Bieber, Thomas
    Biedermann, Tilo
    Braeutigam, Matthias
    Seyfried, Stefan
    Brehler, Randolf
    Grabbe, Juergen
    Hunzelmann, Nicolas
    Jakob, Thilo
    Jung, Andreas
    Kleine-Tebbe, Joerg
    Mempel, Martin
    Meurer, Michael
    Reich, Kristian
    Rueff, Franziska
    Schaekel, Knut
    Sengupta, Kaushik
    Sieder, Christian
    Simon, Jan C.
    Wedi, Bettina
    Zuberbier, Torsten
    Mahler, Vera
    Staubach, Petra
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (01) : 202 - U326
  • [33] Efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria
    Ana, C.
    Silva, P.
    Dias, J.
    Mendes, A.
    Pedro, E.
    Barbosa, M.
    ALLERGY, 2012, 67 : 348 - 349
  • [34] An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria
    Lal Vijayalal, Sandeep
    Arora, Sandeep
    Dabas, Rajeshwari
    Janney, Manasa Shettisara
    Jankal Basavarajappa, Sushma
    Das, Niyor M.
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [35] Chronic spontaneous urticaria (CSU) associated with chronic inducible urticaria (CIndU): Efficacy of omalizumab
    Valle, S. O. R.
    Azizi, G. G.
    Dortas Junior, S. D.
    ALLERGY, 2019, 74 : 610 - 610
  • [36] Safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria
    Maurer, M.
    Rosen, K.
    Hsieh, H.
    Blogg, M.
    Georgiou, P.
    Braeutigam, M.
    Saini, S.
    ALLERGY, 2012, 67 : 497 - 498
  • [37] Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria
    Aude Belbezier
    Isabelle Boccon-Gibod
    Laurence Bouillet
    European Journal of Dermatology, 2021, 31 : 86 - 87
  • [38] Safety of omalizumab in elderly patients with chronic spontaneous urticaria
    Narvaez Fernandez, E. J.
    Mir Ihara, P. K.
    Caballero Molina, T.
    Dominguez-Ortega, J.
    Cabanas Moreno, R.
    Entrala Bueso, A.
    ALLERGY, 2021, 76 : 234 - 234
  • [39] Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria
    Belbezier, Aude
    Boccon-Gibod, Isabelle
    Bouillet, Laurence
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (01) : 86 - 87
  • [40] Use of omalizumab in the treatment of refractory chronic urticaria
    Simon, M.
    Dahan, E.
    Ponrouch, M. P.
    Roch-Torreilles, I.
    Rambourg, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1312 - 1313
12345